Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.
AuteursKouvaraki M, Zerdes I, Sifakis EG, Sarafidis M, Matikas A, Tzoras E, Kjällquist U, Stathopoulou K, Lövrot J, Alkodsi A, Hartman J, Sotiriou C, Richard F, Hatschek T, Herold N, Bergh J, Rassidakis GZ, Foukakis T
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2+ early breast cancer (EBC).
AuteursFernandez-Martinez A, Tanioka M, Ahn SG, Zagami P, Pascual T, Rediti M, Tang G, Hoadley KA, Venet D, Rashid NU, Spears PA, Di Cosimo S, de Azambuja E, Choudhury A, Rastogi P, Islam MN, Cortes J, Llombart-Cussac A, Swain SM, Sotiriou C, Prat A, Perou CM, Carey LA
A Multimodal Patient-Centered Teleprehabilitation Approach for Patients Undergoing Surgery for Breast Cancer: A Clinical Perspective.
AuteursMostaqim K, Lahousse A, Ubaghs S, Timmermans A, Deliens T, Vanhoeij M, Fontaine C, de Jonge E, Van Hoecke J, Polastro L, Lamotte M, Cuesta-Vargas AI, Huysmans E, Nijs J
Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics.
AuteursElliott P, Schunkert H, Bondue A, Behr E, Carrier L, Van Duijn C, García-Pavía P, van der Harst P, Kavousi M, Loeys B, Rocha Lopes L, Pinto Y, Di Toro A, Thum T, Kääb S, Urtis M, Arbustini E
